The Reduction of Serum B‐Lymphocyte Activating Factor levels following Quinacrine Add‐On Therapy in Systemic Lupus ErythematosusElias Toubi, Y Shoenfeld, D. Paran et al.|Scandinavian Journal of Immunology|2006Cited by 41
Quinacrine added to ongoing therapeutic regimens attenuates anticardiolipin antibody production in SLEElias Toubi, Theo Dov Golan, Aharon Kessel et al.|Lupus|2003Cited by 15